Our international team works across six countries to deliver biotech solutions that
revolutionize healthcare.
Our team recognizes Cellular and Molecular Biology research
as fundamental to advancing our
understanding of life at the most basic levels, driving innovation in drug discovery, disease
prevention, and genomic medicine. We employ cutting edge techniques and tools to investigate
the mechanisms underlying cellular function, gene expression, and biochemical interactions.
One major focus at Patravi is the identification and development of new therapeutics. Patravi’s scientists use high-throughput screening, computational modeling, and molecular assays to identify potential drug candidates. These compounds are tested for their ability to interact with specific molecular targets to modulate disease-related pathways . Once promising compounds are identified, researchers analyze their pharmacokinetics, toxicity, and efficacy in model organisms before clinical trials.
Patravi’s advancements in genomics have revolutionized the way our researchers approach medicine. Our Scientists utilize techniques such as next-generation sequencing (NGS), CRISPR, and transcriptomic analysis to study genetic variations and their contributions to diseases. Genomic research allows for the development of treatments tailored to individuals based on their genetic makeup, minimizing adverse effects and maximizing therapeutic efficacy.
Patravi understands the molecular basis of diseases is essential for developing effective treatments and preventative measures. Researchers study cellular signaling pathways, epigenetics, and protein interactions to uncover the root causes of conditions such as cancer, neurodegenerative disorders, and autoimmune diseases. By identifying biomarkers, scientists can develop diagnostic tools that detect diseases at earlier stages, allowing for more effective intervention.